Contents

Search

radium Ra[223] dichloride (Xofigo)

Indications: - treatment of metastatic prostate cancer

General

radium [Ra] antineoplastic agent (chemotherapeutic agent)

References

  1. FDA News Release: May 15, 2013 FDA approves new drug for advanced prostate cancer http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm352363.htm